share_log

Clarus Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-10% Owner THOMAS MCNERNEY & PARTNERS LP

Clarus Therapeutics | 4/A:持股變動聲明(修正)-股東 THOMAS MCNERNEY & PARTNERS LP

2022/04/25 17:17
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息